Patents Examined by Jeff Kughan
  • Tumor therapy with biologically active anti-tumor antibodies
    Patent number: 5091178
    Abstract: A method for identifying and using antibodies which are directed against tumor-associated glycolipid antigens and which are capable of activating serum complement or antibody dependent cellular cytotoxicity. These antibodies find use in the therapy of tumors. Administration of the antibodies results in lysis of the tumor cells in vivo.
    Type: Grant
    Filed: January 30, 1990
    Date of Patent: February 25, 1992
    Assignee: Oncogen
    Inventors: Karl E. Hellstrom, Ingegerd Hellstrom